Market Overview

A Peek Into The Market Before The Trading Starts

Related AMD
For AMD Ryzen Chips, Will Gains In Mindshare Lead To Market Share?
AMD Unveils New Radeon RX Vega GPUs
Related ENG
Mid-Afternoon Market Update: Ionis Pharma Rises After FDA Approval Of Spinraza; Seattle Genetics Shares Plummet
12 Biggest Mid-Day Gainers For Tuesday

Pre-open movers US stock futures are higher this morning, ahead of retail-sales and other economic data. Futures for the Dow Jones Industrial Average surged 29 points to 12,896.00 and S&P 500 index futures rose 3.50 points to 1,371.50. Nasdaq 100 futures gained 4.75 points to 2,646.25.

A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index rose 0.45%, London's FTSE 100 Index surged 0.57%, French CAC 40 Index gained 0.14% and German DAX 30 index rose 0.78%.

Asian markets ended mostly lower, with Japan's Nikkei Stock Average falling 0.27%, China's Shanghai Composite dropping 1.17% and Australia's S&P/ASX 200 dropping 0.09%. Hong Kong's Hang Seng Index gained 0.50%.

Broker Recommendation Analysts at Sterne Agee downgraded Advanced Micro Devices (NYSE: AMD) from “buy” to “neutral.” The target price for Advanced Micro Devices is set to $8.50.

Advanced Micro Devices shares gained 4.87% to close at $6.03 on Tuesday.

Breaking news

  • ENGlobal (NASDAQ: ENG) today announced that it is one of three firms that has been awarded a multiple award contract for the procurement of automated fuel handling equipment (AFHE) support services to the U.S. Military. To read the full news, click here.
  • Acacia Research (NASDAQ: ACTG) announced today that a subsidiary has acquired 4 patent portfolios with 48 U.S. and International patents covering technologies relating to online collaboration, data networking, cellular communications and digital cameras. To read the full news, click here.
  • Agria (NYSE: GRO) today announced that the two-year service contract of Dr. Kenneth J. DeWoskin, who served as a member of the board of directors and the audit committee of the Company, has expired. To read the full news, click here.
  • China Cord Blood (NYSE: CO) today announced that the Company repurchased an aggregate of 2,191,412 ordinary shares for a total consideration of approximately $6.2 million since August 2011. To read the full news, click here.

Posted-In: Sterne Agee US Stock FuturesNews Futures Global Pre-Market Outlook Markets


Related Articles (ACTG + AMD)

View Comments and Join the Discussion!